ASRT
Assertio Holdings Inc
A pharmaceutical company that markets and sells branded prescription medicines, focusing on oncology, neurology, and pain and inflammation care. Founded in 1995 as Depomed, it started with a drug-delivery technology that made pills swell in the stomach for slow, steady release of their medicine. It rebranded as Assertio in 2018 — a name chosen to reflect an "aspirational, assertive mindset" — and its lineup has included pain relievers like Indocin and Sprix, plus the migraine drug Cambia.
CUSIP: 04545L107HealthcareUS1 holder